Diffusion tensor imaging and behavior in premature infants at 8 years of age, a randomized controlled trial with

Astrid Nylander Almaas1, Christian K Tamnes2, Britt Nakstad3

  • 1Akershus University Hospital and Faculty Division AHUS, Institute for Clinical Medicine, University of Oslo, Nordbyhagen, Norway; Department of Nutrition, Institute of Basic Medical Sciences, Faculty of Medicine, University of Oslo, Norway.

Insights

Postnatal supplementation with docosahexaenoic acid (DHA) and arachidonic acid (AA) did not improve white matter microstructure or behavioral outcomes in very low birth weight (VLBW) infants at 8 years. This study explored long-term effects in VLBW children.

Area of Science:

  • Neuroscience
  • Developmental Pediatrics
  • Nutritional Science

Background:

  • Very low birth weight (VLBW) infants face higher risks of behavioral issues and show reduced white matter maturation.
  • Long-chain polyunsaturated fatty acids (LCPUFAs) like DHA and AA are hypothesized to enhance myelination and improve neurodevelopmental outcomes.

Purpose of the Study:

  • To evaluate the long-term impact of postnatal DHA and AA supplementation on cerebral white matter microstructure and behavioral outcomes in VLBW infants.
  • To test the hypothesis that LCPUFA supplementation positively influences brain development and behavior in VLBW children.

Main Methods:

  • An 8-year follow-up of a randomized, double-blinded, placebo-controlled trial involving 129 VLBW infants fed human milk.
  • Cerebral white matter integrity was assessed using Diffusion Tensor Imaging (DTI).
  • Behavioral outcomes were measured using the Strengths and Difficulties Questionnaire and Child Behavior Checklist.

Main Results:

  • No significant differences were observed in white matter microstructure between the DHA/AA supplemented group and the placebo group.
  • Behavioral assessments at 8 years of age showed no significant differences between the groups.
  • A trend towards higher fractional anisotropy in the corpus callosum in the supplemented group was noted but did not reach statistical significance.

Conclusions:

  • Postnatal supplementation with DHA and AA in human milk-fed VLBW infants did not lead to significant improvements in white matter microstructure or behavioral outcomes by 8 years of age.
  • This study provides crucial long-term data on the efficacy of LCPUFA supplementation for neurodevelopment in VLBW populations.
  • Further research may be needed to explore optimal LCPUFA dosages or alternative interventions for VLBW infants.
Abstract